Hospital Clínico Universitario Virgen de la Arrixaca

El Palmar, Murcia 30120

4 studies enrolling now · 9 studies all time

What they study most

AL Amyloidosis, Acinar Cell Carcinoma, Advanced Cancer, Amyloidosis, Breast Cancer, Colorectal Cancer, Colorectal Cancer Stage I, Coronary Artery Disease, Endometrial Cancer, Fallopian Tube Cancer, Follicular Lymphoma, HER2-Positive Primary Breast Cancer

Studies at this site

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — Recruiting now
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) — Recruiting now
• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia — Recruiting now
• CRF2 Agonist for the Treatment of Worsening Heart Failure — Paused
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis — Completed
• Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer — Status unconfirmed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed